BIOMAT Database Logo BIOMAT Database Logo

Glycyrrhizin inhibits neutrophil-associated generation of alternatively activated macrophages. 2006

Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Department of Internal Medicine, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0435, USA.

Patients with severe burn injuries are extremely susceptible to infection, and the host's antibacterial responses are frequently suppressed by alternatively activated macrophages (M2Mphi), commonly demonstrated in these patients. An immunosuppressive subset of neutrophils (PMN-II), demonstrated in the peripheral blood of thermally injured patients, has been described as an inducer of M2Mphi. In the present studies, the inhibitory effect of glycyrrhizin (GL) on M2Mphi generation stimulated by PMN-II was examined. M2Mphi were generated from resident Mphi (R-Mphi, lower chamber) after cultivation with PMN-II (upper chamber) in a dual-chamber transwell. However, M2Mphi were not generated from R-Mphi when the same transwell cultures were performed in the presence of GL. M2Mphi were not generated from R-Mphi after cultivation with PMN-II previously treated with GL, while R-Mphi previously treated with GL converted to M2Mphi after they were cultured with PMN-II in transwells. Interleukin-10 and CCL2 released from PMN-II were shown to be effector molecules responsible for the generation of M2Mphi. However, these soluble factors were not produced by PMN-II treated with GL. These results indicate that GL inhibits PMN-II-stimulated M2Mphi generation through the inhibition of CCL2/interleukin-10 production by PMN-II.

UI MeSH Term Description Entries
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006131 Growth Inhibitors Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth ( Cell Growth Inhibitor,Cell Growth Inhibitors,Growth Inhibitor,Growth Inhibitor, Cell,Growth Inhibitors, Cell,Inhibitor, Cell Growth,Inhibitor, Growth,Inhibitors, Cell Growth,Inhibitors, Growth
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016753 Interleukin-10 A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein. IL-10,CSIF-10,Cytokine Synthesis Inhibitory Factor,IL10,Interleukin 10

Related Publications

Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
SHIP represses the generation of alternatively activated macrophages.
October 2005, Immunity,
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Generation and characterization of murine alternatively activated macrophages.
January 2013, Methods in molecular biology (Clifton, N.J.),
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Macrophages in malignant pleural effusions - alternatively activated tumor associated macrophages.
January 2012, Contemporary oncology (Poznan, Poland),
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats.
November 1981, Prostaglandins and medicine,
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Attributes of alternatively activated (M2) macrophages.
May 2019, Life sciences,
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis.
April 2011, Science (New York, N.Y.),
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages.
February 2004, Journal of immunology (Baltimore, Md. : 1950),
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Alternatively activated macrophages in helminth infections.
August 2007, Current opinion in immunology,
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Pancreatitis: Alternatively activated macrophages mediate fibrosis.
July 2015, Nature reviews. Gastroenterology & hepatology,
Tsuyoshi Yoshida, and Yasuhiro Tsuda, and Dan Takeuchi, and Makiko Kobayashi, and Richard B Pollard, and Fujio Suzuki
Alternatively activated macrophages and airway disease.
September 2011, Chest,
Copied contents to your clipboard!